B+
Bull case
20%
Probability
Target price
$1.50
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
ARTL
Artelo BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
ART26.12 has encouraging company-reported preclinical pain data and a potentially differentiated safety profile, creating asymmetric upside if clinical translation succeeds [#PR-EARNINGS-2026-07-16].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
No confirmed dated clinical, regulatory, partnering, or financing milestone is available.
Momentum
1
Value
59
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.68 · Bull $1.50 · Bear $0.30Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $5.00
Why
Momentum1 · Δ7d -
Value59 · Δ7d 0.0
Sentiment0 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • No confirmed dated clinical, regulatory, partnering, or financing milestone is available.
- • No recent news set, social coverage, or analyst revision data is available.
- • The company is a roughly $2.6 million micro-cap biotech with limited forward visibility.
Catalyst clock
2026-07-16
ART26.12 osteoarthritis nonclinical data
Lead driver: Value · See fundamentals
Momentum
1
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
59
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.9
Sentiment
0
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 1.1 / Value 58.7 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$0.68
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.30
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$3.31M
Beta
1.11
Shares Out
3.49M
P/E (TTM) · Derived
-0.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.04
Rev YoY
-
EPS YoY
-94.7%
Gross Margin
-
Op Margin
-
Net Debt
$78K
Current Ratio
3.00
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data